GE HealthCare launches AI-enhanced personalised oncology solutions

GE HealthCare has announced Revolution RT, a new radiation therapy computed tomography (CT) solution with innovative hardware and software solutions to help increase imaging accuracy while simplifying simulation workflow for a more personalized and seamless oncology care pathway experience for clinicians and patients.

The new Revolution RT is being unveiled at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2024 Congress in Glasgow, in May 2024, along with an updated and artificial intelligence (AI)-enhanced version of the Intelligent Radiation Therapy (iRT) platform, which interfaces with the Spectronic magnetic resonance imaging (MRI) Planner.
 
GE HealthCare designed its new Revolution RT with a wide-bore CT platform and high-performance radiation therapy simulation, diagnostic, and interventional capabilities to accommodate more patients and create a more streamlined standard of care. Revolution RT includes precision radiotherapy simulation that will help enable more accurate imaging while improving workflow and efficiency, and using deep learning technology to help image the patient with accuracy. Its newly updated platform ‘iRT’ enables greater interoperability, connectivity, and efficiency throughout the entirety of the radiation oncology care continuum and includes key features such as an integrated workflow that connects various applications into an intuitive single interface, multi-vendor interoperability, seamless data transfer and task automation, and a catalog of RT applications from both GE HealthCare and third parties.

The company is unveiling multiple updates to the iRT platform, which highlight its vendor-agnostic ecosystem, such as MR Direct with Spectronic Medical, Simplified Planning with MIM, InstaPlan with RaySearch, and personalisation.